Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,422 | -29,861 | -122,176 | -93,524 | -59,794 |
| Depreciation Amortization | 1,050 | 517 | 2,216 | 1,678 | 1,090 |
| Accounts payable and accrued liabilities | 636 | 159 | 159 | 1,075 | 877 |
| Other Working Capital | -5,703 | -4,645 | 2,068 | 6,673 | 5,653 |
| Other Operating Activity | 8,981 | 4,898 | 21,008 | 15,219 | 10,462 |
| Operating Cash Flow | $-55,458 | $-28,932 | $-96,725 | $-68,879 | $-41,712 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -385 | -153 | -1,481 | -1,956 | -1,147 |
| Investing Cash Flow | $-385 | $-153 | $-1,481 | $-1,956 | $-1,147 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 14,778 | 14,778 | 14,778 |
| Common Stock Issued | 79,251 | 129 | 82,762 | 82,888 | 82,557 |
| Other Financing Activity | 0 | -12 | 0 | 0 | 0 |
| Financing Cash Flow | $79,251 | $117 | $97,540 | $97,666 | $97,335 |
| Beginning Cash Position | 69,754 | 69,754 | 70,420 | 70,420 | 70,420 |
| End Cash Position | 93,162 | 40,786 | 69,754 | 97,251 | 124,896 |
| Net Cash Flow | $23,408 | $-28,968 | $-666 | $26,831 | $54,476 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,458 | -28,932 | -96,725 | -68,879 | -41,712 |
| Capital Expenditure | -385 | -153 | -1,519 | -1,962 | -1,151 |
| Free Cash Flow | -55,843 | -29,085 | -98,244 | -70,841 | -42,863 |